United States Federal Circuit

The district court's judgment that various claims of the nine patents-in-suit related to a drug used in treating multiple sclerosis, are infringed, and the court's holdings that the claims were not indefinite, not enabled, or obvious, is: 1) affirmed in part, where the district court did not err in its conclusions that the claims are infringed, that defendants failed to prove that the claims would have been obvious and are not enabled, and that defendants failed to prove that Group II claims are indefinite; but 2) reversed in part and remanded, where the Group I claims are invalid for indefiniteness.

Appellate Information

• Decided 07/26/2013
• Published 07/26/2013

Judges

• MOORE

Court

• United States Federal Circuit

Counsel